Yoko Shishikura

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 173 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Effects of Tea Polyphenols on Emulsification of Olive Oil in a Small Intestine Model System

Yoko Shishikura, Santosh Khokhar, Brent S. Murray · Journal of Agricultural and Food Chemistry · 2006 · 172 citations

Agriculture, Food Science, Nutritional Sciences +17

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

Beatriz Baragaña, Barbara Forte, Ryan Choi et al. · Proceedings of the National Academy of Sciences · 2019 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability

Graham Lappin, Yoko Shishikura, Roeline Jochemsen et al. · European Journal of Pharmaceutical Sciences · 2010 · 113 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and <i>Mycobacterium tuberculosis</i>: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization

Dinakaran Murugesan, Peter C. Ray, Tracy Bayliss et al. · ACS Infectious Diseases · 2018 · 76 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15